Skip to main content

Table 4 Univariate and multivariate regression analysis to identify predictors for hepatotoxicity related to erlotinib administration in pancreatic cancer patients

From: Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study

Characteristics Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Male 0.957 (0.491–1.865) 1.279 (0.598–2.737)
Age ≥ 65 0.858 (0.444–1.656) 0.731 (0.369–1.448)
BSA ≥ 1.6a 0.652 (0.336–1.268) 0.549 (0.255–1.180)
CYP3A4 Inducer 3.690 (0.886–15.679) 4.114 (0.969–17.465)
  1. For multivariate analysis, factors with p < 0.1 in the univariate analysis were included in addition to sex, age and BSA
  2. BSA body surface area
  3. aThere was 1 missing data for BSA